Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hodgkin Disease × Inositol × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 30 Insulin Resistance 5 Infertility 5 Hyperandrogenism 3 Anovulation 3 Pre-Eclampsia 2 Metabolic Syndrome 2 Infertility, Female 2 Glucose Intolerance 2 Diabetes, Gestational 2 Carcinoma, Non-Small-Cell Lung 2 Weight Loss 1 Thyroid Nodule 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms 1 Premature Birth 1 Precancerous Conditions 1 Oligomenorrhea 1 Menstruation Disturbances 1 Lung Neoplasms 1 Inflammation 1 Hodgkin Disease 1 Colonic Neoplasms 1 Amenorrhea 1

Interventions

Cyclophosphamide 172 fludarabine phosphate 97 Etoposide 97 Peripheral Blood Stem Cell Transplantation 83 Filgrastim 78 Mycophenolic Acid 74 Doxorubicin 72 Whole-Body Irradiation 69 Melphalan 69 Radiotherapy 66 Brentuximab Vedotin 66 fludarabine 61 Tacrolimus 61 Busulfan 60 Cyclosporine 54 Vinblastine 53 Rituximab 52 Dacarbazine 46 Bleomycin 45 Granulocyte Colony-Stimulating Factor 44 Gemcitabine 42 Vincristine 40 Prednisone 40 Cytarabine 40 Antilymphocyte Serum 40 Methotrexate 35 Carmustine 33 Nivolumab 32 pembrolizumab 31 Sirolimus 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05410314 2022-06-08

Linf-inositol

University of Bari Aldo Moro

Hodgkin Disease, Menstruation Disturbances

Data powered by HemOnc (CC BY 4.0) Colophon ⚡